A detailed history of Finer Wealth Management, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Finer Wealth Management, Inc. holds 16,249 shares of PFE stock, worth $422,798. This represents 0.29% of its overall portfolio holdings.

Number of Shares
16,249
Previous 44,452 63.45%
Holding current value
$422,798
Previous $1.24 Million 62.19%
% of portfolio
0.29%
Previous 0.8%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$27.7 - $31.39 $781,223 - $885,292
-28,203 Reduced 63.45%
16,249 $470,000
Q2 2024

Aug 13, 2024

SELL
$25.26 - $29.6 $405,018 - $474,606
-16,034 Reduced 26.51%
44,452 $1.24 Million
Q1 2024

Apr 26, 2024

SELL
$25.89 - $29.73 $375,275 - $430,936
-14,495 Reduced 19.33%
60,486 $1.68 Million
Q4 2023

Feb 13, 2024

SELL
$26.13 - $33.94 $267,100 - $346,934
-10,222 Reduced 12.0%
74,981 $2.16 Million
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $126,562 - $147,939
3,944 Added 4.85%
85,203 $2.83 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $53,782 - $62,225
1,489 Added 1.87%
81,259 $2.98 Million
Q1 2023

May 09, 2023

BUY
$39.39 - $51.28 $230,982 - $300,705
5,864 Added 7.93%
79,770 $3.25 Million
Q4 2022

Feb 13, 2023

BUY
$41.75 - $54.5 $8,266 - $10,791
198 Added 0.27%
73,906 $3.79 Million
Q3 2022

Nov 10, 2022

SELL
$43.76 - $53.42 $4,988 - $6,089
-114 Reduced 0.15%
73,708 $3.23 Million
Q2 2022

Aug 10, 2022

BUY
$46.53 - $55.17 $22,846 - $27,088
491 Added 0.67%
73,822 $3.87 Million
Q1 2022

Jun 06, 2022

BUY
$45.75 - $56.69 $74,069 - $91,781
1,619 Added 2.26%
73,331 $3.8 Million
Q4 2021

Jun 01, 2022

BUY
$41.32 - $61.25 $2.96 Million - $4.39 Million
71,712 New
71,712 $4.24 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $146B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Finer Wealth Management, Inc. Portfolio

Follow Finer Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Finer Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Finer Wealth Management, Inc. with notifications on news.